Sign in Subscribe
COVID-19

Ionizable Lipid Nanoparticles for mRNA Delivery: Shedding Light on Endosomal Escape Efficiency

Strategic Insights

— 1 min read

A recent breakthrough in gene therapy has been reported by researchers from the Royal Melbourne Institute of Technology - RMIT University, as they delve into the intricacies of ionizable lipid nanoparticles (LNPs) used in mRNA vaccines. By applying cutting-edge techniques such as time-resolved synchrotron radiation small-angle X-ray scattering (SAXS), the team has established a crucial link between the internal nanostructure of LNPs and their efficiency in delivering mRNA to cells.

Key Takeaways:

  • The research highlights the importance of ionizable lipids, such as ALC-0315 and SM-102, used in Moderna and Pfizer-BioNTech vaccines, in facilitating endosomal escape and intracellular transfection of therapeutic mRNAs.
  • The study reveals that the internal nanostructural evolution of LNPs during endosomal maturation significantly influences mRNA release, endosomal escape, and gene expression.
  • High-throughput and cutting-edge techniques such as SAXS have been employed to investigate the self-assembly and structural transitions of ionizable LNPs with and without nucleic acid cargos upon acidification.
  • The influence of helper lipids, cholesterol, and protein coronas formed upon exposure to biological environments on the physicochemical properties and mesophase behavior of LNPs has been explored.
  • The research suggests that protein corona-modulated phase behavior of LNPs may contribute to inconsistency between and performance.
  • The study offers a perspective on future research trends in improving endosomal escape efficiency, promoting a passive nonendocytic cellular uptake pathway, modulating protein corona effects, and leveraging of artificial intelligence approaches to accelerate formulation design and screening.

Statistics:

  • The research employed high-throughput and cutting-edge time-resolved synchrotron radiation small-angle X-ray scattering (SAXS) to investigate the self-assembly and structural transitions of ionizable LNPs.
  • The study analyzed two COVID-19 mRNA vaccine ionizable lipids, ALC-0315 and SM-102.
  • The research explored the influence of select structure-forming helper lipids, such as monoolein and phytantriol, and cholesterol, on the physicochemical properties, mesophase behavior, and gene delivery performance of LNPs.
  • The study found that protein corona-modulated phase behavior of LNPs may contribute to inconsistency between and performance.

Sources:

  • NewsRx. New Gene Therapy Findings from Royal Melbourne Institute of Technology - RMIT University Outlined (Ionizable Lipid Nanoparticles for mRNA Delivery: Internal Self-Assembled Inverse Mesophase Structure and Endosomal Escape). Pharma Business Week. October 20, 2025; p 128.
  • Ionizable Lipid Nanoparticles for mRNA Delivery: Internal Self-Assembled Inverse Mesophase Structure and Endosomal Escape. Accounts of Chemical Research, 2025.

Read more